BiotechTube
Bioassay Works

Bioassay Works

Frederick, United States· Est.
bioassayworks.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.3M

Overview

BioAssay Works is a privately held, revenue-generating CDMO with over 20 years of experience in the lateral flow assay market. The company leverages its proprietary gold nanoparticle technology (Naked Gold® and Dressed Gold®) and patented C-Flat® assay platform to develop and manufacture high-sensitivity rapid tests for partners across human diagnostics, veterinary, food safety, environmental, and biodefense sectors. Operating from an ISO 13485:2016 certified facility in Frederick, Maryland, BAW positions itself as an end-to-end innovation partner, helping clients accelerate product development from concept to commercial scale.

Diagnostics

Technology Platform

Proprietary high-sensitivity gold nanoparticle reagents (Naked Gold®, Dressed Gold®) and a patented lateral flow assay platform (C-Flat®) designed to deliver ELISA-level sensitivity in rapid, point-of-care formats.

Funding History

2
Total raised:$1.3M
Seed$800K
Grant$500K

Opportunities

The growing demand for quantitative, high-sensitivity lateral flow assays in clinical and non-clinical settings presents a major opportunity.
Expansion into adjacent verticals like veterinary diagnostics, food safety, and environmental monitoring offers diversified growth beyond human healthcare.

Risk Factors

Revenue is dependent on a continuous stream of client projects, creating vulnerability to downturns in diagnostic funding.
Technological disruption from alternative labels (e.g., fluorescent beads) could challenge its gold nanoparticle-centric platform.
Maintaining complex supply chains and regulatory compliance for medical device manufacturing poses operational risks.

Competitive Landscape

BAW competes with other specialized LFA CDMOs (e.g., Abingdon Health, BBI Solutions, Immunostrip) and large diagnostic firms with internal development capabilities. Its differentiation lies in its proprietary gold nanoparticle technology, focus on sensitivity, and full-service, ISO 13485-certified turnkey model for a broad range of industrial and diagnostic applications.

More companies in United States →